Analysis of factors predicting outcome of peginterferon plus ribavirin combination therapy for chronic hepatitis C-comparison between NK cell activity and other possible predictors

Analysis of factors predicting outcome of peginterferon plus ribavirin combination therapy for chronic hepatitis C-comparison between NK cell activity and other possible predictors - NK cell activity in IFN therapy for chronic hepatitis C

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003866

Enrollment

Registered

2010-08-01

Start date

2010-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis C

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: genotype 1b and high viral load (greater than 5.0LogIU/mL)

Exclusion criteria

Exclusion criteria: liver cirrhosis autoimmune hepatitis primary biliary cirrhosis malignancy depression drug abuse pregnant or lactating woman

Design outcomes

Primary

Measure	Time frame
Involvement of pretreatment NK cell activity with sustained virological response and non-response	—

Countries

Japan

Outcome results